HR Execs on the Move

Praxsyn

www.praxsyn.com

 
Headquartered in Irvine, California, Praxsyn works to realize the vision of medical professionals to improve the lives of patients. Mesa Pharmacy, a wholly owned subsidiary, provides doctors with an alternative to oral pain medications. Mesa focuses on providing custom compounded non-narcotic, transdermal topical pain medications that are marketed to industrial health physicians and medical clinics. Mesa has developed a series of topical creams, in different strengths, that provide the pain relief doctors seek for their patients.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.praxsyn.com
  • 1803 Sky Park Circle Suite A
    Irvine, CA USA 92614
  • Phone: 949.777.6112

Executives

Name Title Contact Details

Similar Companies

Genius Therapy

Genius Therapy LLC is an early intervention agency that was founded to promote and enhance the development of infants and young children with special needs between the ages of birth to three. Our mission is for all children with special needs to achieve their maximum personal development both as individuals and as learners. At Genius Therapy, we develop programs designed specifically for each child, utilizing the principles of special instruction, applied behavioral analysis, occupational therapy and speech and language therapy.

Salience Learning

We are Salience Learning. We help solve life science’s most complex business challenges by delivering transformative learning experiences.

Abece

Abece is a Miami Beach, FL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

J M Smith Corporation

J M Smith Corporation is a Spartanburg, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Delcath

Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. The company`s proprietary percutaneous hepatic perfusion (PHP) system is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. In the United States, the PHP system is being developed under the tradename HEPZATO KIT (melphalan hydrochloride for injection/hepatic delivery system), or HEPZATO, and is considered a combination drug and device product regulated by the United States Food and Drug Administration (FDA).